Chemoinformaics analysis of 2,4-Imidazolidinedione
Molecular Weight | 100.077 | nRot | 0 |
Heavy Atom Molecular Weight | 96.045 | nRig | 6 |
Exact Molecular Weight | 100.027 | nRing | 1 |
Solubility: LogS | -1.166 | nHRing | 1 |
Solubility: LogP | -0.892 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 11 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 7 | No. of Aromatic Carbocycles | 0 |
nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 4 | No. of Saturated Hetero Cycles | 1 |
No. of Carbon atom | 3 | No. of Saturated Rings | 1 |
No. of Nitrogen atom | 2 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 11.4812 |
nHD | 2 | BPOL | 6.88883 |
QED | 0.407 |
Synth | 3.482 |
Natural Product Likeliness | -0.025 |
NR-PPAR-gamma | 0.001 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0.004 |
HIA | 0.904 |
CACO-2 | -5.411 |
MDCK | 0.0000159 |
BBB | 0.114 |
PPB | 0.0704899 |
VDSS | 0.611 |
FU | 0.8735 |
CYP1A2-inh | 0.014 |
CYP1A2-sub | 0.971 |
CYP2c19-inh | 0.033 |
CYP2c19-sub | 0.053 |
CYP2c9-inh | 0.01 |
CYP2c9-sub | 0.229 |
CYP2d6-inh | 0.006 |
CYP2d6-sub | 0.052 |
CYP3a4-inh | 0.006 |
CYP3a4-sub | 0.127 |
CL | 9.889 |
T12 | 0.929 |
hERG | 0.021 |
Ames | 0.025 |
ROA | 0.184 |
SkinSen | 0.177 |
Carcinogencity | 0.269 |
EI | 0.905 |
Respiratory | 0.083 |
NR-Aromatase | 0.003 |
Antiviral | No |
Prediction | 0.973667 |